Comment on Lundby et al.'s "Testing for recombinant human erythropoietin in urine: Problems associated with current anti-doping testing" [4]

Journal of Applied Physiology

Volumn 105, Issue 6, 2008, Pages 1992-

  Lippi, Giuseppe ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ATHLETE; DIAGNOSTIC TEST; DOPING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; LETTER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINALYSIS; METHODOLOGY; NOTE; URINE;

DOPING IN SPORTS; ERYTHROPOIETIN, RECOMBINANT; HUMANS;

EID: 57349162235     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.zdg-8310-comm.2008     Document Type: Letter

References (5)

1. Kayser B, Mauron A, Miah A. Current anti-doping policy: a critical appraisal. BMC Med Ethics 8: 2, 2007.
2. Lippi G, Banfi G, Franchini M, Guidi GC. New strategies for doping control. J Sports Sci 26: 441-445, 2008.
3. Lippi G, Franchini M, Guidi GC. Doping in competition or doping in sport? Br Med Bull 86: 95-107, 2008.
4. Lippi G, Franchini M, Guidi GC. Haematological testing and antidoping policies. Int J Sports Med 26: 508-509, 2005.
5. Lundby C, Achman-Andersen NJ, Thomsen NJ, Norgaard AM, Robach P. Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing. J Appl Physiol 105: 417-419, 2008. First published June 26, 2008;